-
Designing better trials for epilepsy medications: the challenge of heterogeneity
Daniel Friedman, Jacqueline A French
Clinical Trail Methodology: Clinical Investigation
-
Designing better trials for epilepsy medications: the challenge of heterogeneity
Daniel Friedman, Jacqueline A French
Clinical Trail Methodology: Clinical Investigation
-
Designing better trials for epilepsy medications: the challenge of heterogeneity
Daniel Friedman, Jacqueline A French
Clinical Trail Methodology: Clinical Investigation
-
Designing better trials for epilepsy medications: the challenge of heterogeneity
Daniel Friedman, Jacqueline A French
Clinical Trail Methodology: Clinical Investigation
-
Designing better trials for epilepsy medications: the challenge of heterogeneity
Daniel Friedman, Jacqueline A French
Clinical Trail Methodology: Clinical Investigation
-
Designing better trials for epilepsy medications: the challenge of heterogeneity
Daniel Friedman, Jacqueline A French
Clinical Trail Methodology: Clinical Investigation
-
Designing better trials for epilepsy medications: the challenge of heterogeneity
Daniel Friedman, Jacqueline A French
Clinical Trail Methodology: Clinical Investigation
-
Designing better trials for epilepsy medications: the challenge of heterogeneity
Daniel Friedman, Jacqueline A French
Clinical Trail Methodology: Clinical Investigation
-
Challenges and opportunities in the design and implementation of breast cancer clinical trials in the developing countries
Sudeep Gupta, Shona Nag, Shaheenah Dawood
Clinical Trail Perspective: Clinical Investigation
-
Challenges and opportunities in the design and implementation of breast cancer clinical trials in the developing countries
Sudeep Gupta, Shona Nag, Shaheenah Dawood
Clinical Trail Perspective: Clinical Investigation
-
Challenges and opportunities in the design and implementation of breast cancer clinical trials in the developing countries
Sudeep Gupta, Shona Nag, Shaheenah Dawood
Clinical Trail Perspective: Clinical Investigation
-
Challenges and opportunities in the design and implementation of breast cancer clinical trials in the developing countries
Sudeep Gupta, Shona Nag, Shaheenah Dawood
Clinical Trail Perspective: Clinical Investigation
-
Challenges and opportunities in the design and implementation of breast cancer clinical trials in the developing countries
Sudeep Gupta, Shona Nag, Shaheenah Dawood
Clinical Trail Perspective: Clinical Investigation
-
Challenges and opportunities in the design and implementation of breast cancer clinical trials in the developing countries
Sudeep Gupta, Shona Nag, Shaheenah Dawood
Clinical Trail Perspective: Clinical Investigation
-
Challenges and opportunities in the design and implementation of breast cancer clinical trials in the developing countries
Sudeep Gupta, Shona Nag, Shaheenah Dawood
Clinical Trail Perspective: Clinical Investigation
-
Challenges and opportunities in the design and implementation of breast cancer clinical trials in the developing countries
Sudeep Gupta, Shona Nag, Shaheenah Dawood
Clinical Trail Perspective: Clinical Investigation
-
Hypocretin receptor antagonists for insomnia: rationale and clinical data
Chad Ruoff, Christian Guilleminault
Review: Clinical Trail Outcomes: Clinical Investigation
-
Hypocretin receptor antagonists for insomnia: rationale and clinical data
Chad Ruoff, Christian Guilleminault
Review: Clinical Trail Outcomes: Clinical Investigation
-
Hypocretin receptor antagonists for insomnia: rationale and clinical data
Chad Ruoff, Christian Guilleminault
Review: Clinical Trail Outcomes: Clinical Investigation
-
Hypocretin receptor antagonists for insomnia: rationale and clinical data
Chad Ruoff, Christian Guilleminault
Review: Clinical Trail Outcomes: Clinical Investigation
-
Hypocretin receptor antagonists for insomnia: rationale and clinical data
Chad Ruoff, Christian Guilleminault
Review: Clinical Trail Outcomes: Clinical Investigation
-
Hypocretin receptor antagonists for insomnia: rationale and clinical data
Chad Ruoff, Christian Guilleminault
Review: Clinical Trail Outcomes: Clinical Investigation
-
Hypocretin receptor antagonists for insomnia: rationale and clinical data
Chad Ruoff, Christian Guilleminault
Review: Clinical Trail Outcomes: Clinical Investigation
-
Hypocretin receptor antagonists for insomnia: rationale and clinical data
Chad Ruoff, Christian Guilleminault
Review: Clinical Trail Outcomes: Clinical Investigation
-
Outcome measures for clinical trials assessing treatment of cystic fibrosis lung disease
Donald R VanDevanter,Michael W Konstan
Clinical Trail Methodology: Clinical Investigation
-
Outcome measures for clinical trials assessing treatment of cystic fibrosis lung disease
Donald R VanDevanter,Michael W Konstan
Clinical Trail Methodology: Clinical Investigation
-
Outcome measures for clinical trials assessing treatment of cystic fibrosis lung disease
Donald R VanDevanter,Michael W Konstan
Clinical Trail Methodology: Clinical Investigation
-
Outcome measures for clinical trials assessing treatment of cystic fibrosis lung disease
Donald R VanDevanter,Michael W Konstan
Clinical Trail Methodology: Clinical Investigation
-
Outcome measures for clinical trials assessing treatment of cystic fibrosis lung disease
Donald R VanDevanter,Michael W Konstan
Clinical Trail Methodology: Clinical Investigation
-
Outcome measures for clinical trials assessing treatment of cystic fibrosis lung disease
Donald R VanDevanter,Michael W Konstan
Clinical Trail Methodology: Clinical Investigation
-
Outcome measures for clinical trials assessing treatment of cystic fibrosis lung disease
Donald R VanDevanter,Michael W Konstan
Clinical Trail Methodology: Clinical Investigation
-
Outcome measures for clinical trials assessing treatment of cystic fibrosis lung disease
Donald R VanDevanter,Michael W Konstan
Clinical Trail Methodology: Clinical Investigation
-
Promising results for new influenza drug presented at the Infectious Diseases Society of America Annual Meeting
News and Views: Clinical Investigation
-
Promising results for new influenza drug presented at the Infectious Diseases Society of America Annual Meeting
News and Views: Clinical Investigation
-
Promising results for new influenza drug presented at the Infectious Diseases Society of America Annual Meeting
News and Views: Clinical Investigation
-
Promising results for new influenza drug presented at the Infectious Diseases Society of America Annual Meeting
News and Views: Clinical Investigation
-
Promising results for new influenza drug presented at the Infectious Diseases Society of America Annual Meeting
News and Views: Clinical Investigation
-
Promising results for new influenza drug presented at the Infectious Diseases Society of America Annual Meeting
News and Views: Clinical Investigation
-
Promising results for new influenza drug presented at the Infectious Diseases Society of America Annual Meeting
News and Views: Clinical Investigation
-
Promising results for new influenza drug presented at the Infectious Diseases Society of America Annual Meeting
News and Views: Clinical Investigation